What Fueled The Previous Growth In The Aminoglycosides Market?
The aminoglycosides market has seen considerable growth due to a variety of factors.
• Over the past years, the aminoglycosides market has experienced consistent expansion. It's anticipated to increase from $1.84 billion in 2024 to $1.93 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 4.9%. This market expansion during the historic timeframe has been affected by various factors, including the discovery and refinement of antibiotics, breakthroughs in medicinal chemistry, clinical effectiveness against gram-negative infections, broad-spectrum antibacterial activity, control of hospital-acquired infections, global population increase, prevention of post-operative infections, and investments in research and development.
How Does the Forecast Look for the Aminoglycosides Market?
The Aminoglycosides market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations for the aminoglycosides market size project robust expansion in the coming years, with a predicted valuation of $2.46 billion by 2029, reflecting a compound annual growth rate (CAGR) of 6.3%.
The predicted growth within this period can be traced back to various factors such as progress in antibiotic stewardship, the rise of personalized medicine, revolutionary developments in drug delivery systems, the worldwide proliferation of antibiotic-resistant strains, a heightened focus on rare diseases, and broadening dermatology applications. Patient education on antibiotic use also contributes to this growth. Projection trends within this period are hinged on biotechnological advancements, the advent of combination therapies, and technological strides in production, alongside price competition.
What Are The Leading Drivers Of Growth In The Aminoglycosides Market?
An increase in the prevalence of animal diseases is a key factor expected to boost the growth of the aminoglycosides market. Animal diseases disrupt or alter the regular activities of an animal. Aminoglycosides, such as amikacin and gentamicin, are frequently used in veterinary medicine. For example, an anthrax outbreak - a disease that affects humans and other mammals - was reported and observed in July 2022 in the remote regions of Canada's largest national park, Wood Buffalo National Park. As a result, the escalation in animal disease outbreaks will persistently fuel the aminoglycosides market.
How Are The Segments Defined Within The Global Aminoglycosides Market?
The aminoglycosides market covered in this report is segmented –
1) By Product: Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin, Other Products
2) By Route Of Administration: Injectables (Parenteral), Feed, Intra-Mammary, Topical, Oral
3) By Application: Veterinary, Skin Infection, Respiratory Diseases, UTI And Pelvic Diseases, Other Diseases
Subsegments:
1) By Neomycin: Topical Formulations, Oral Formulations
2) By Tobramycin: Inhalation Solutions, Injectable Formulations, Ophthalmic Solutions
3) By Gentamicin: Injectable Formulations, Topical Formulations, Ophthalmic Solutions
4) By Amikacin: Injectable Formulations, Inhalation Solutions
5) By Paromomycin: Oral Formulations, Injectable Formulations
6) By Streptomycin: Injectable Formulations, Combination Therapies
7) By Kanamycin: Injectable Formulations, Oral Formulations
8) By Other Products: Combinations Of Aminoglycosides, Novel Aminoglycoside Derivatives
Pre-Book The Aminoglycosides Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Expected To Influence The Growth Of The Aminoglycosides Market?
A pivotal trend within the aminoglycosides market is process innovation. Many large-scale companies in the aminoglycosides market are concentrating on the evolution of new process solutions to fortify their market standing. For example, in February 2024, Cipla Limited, a pharmaceutical corporation based in India, obtained approval from the Central Drugs Standard Control Organization (CDSCO) for the introduction of ZEMDRI (plazomicin), an intravenous aminoglycoside antibiotic, in India. This antibiotic is primarily used in treating complicated urinary tract infections (cUTIs), including pyelonephritis.
Who Are the Key Players In The Aminoglycosides Market?
Major companies operating in the aminoglycosides market include:
• Kremoint Pharma Pvt. Ltd.
• Vega Pharma Ltd.
• Jiangxi Bolai Pharmacy Co. Ltd.
• Xian Wison Biological Technology Co. Ltd.
• Hangzhou Uniwise International Co. Ltd.
• HuvePharma Inc.
• Yi Chang Veterinary Medicine Factory
• Medson Pharmaceuticals
• Medico Remedies Pvt. Ltd.
• Cipla Limited
• Pfizer Inc.
• Allergan PLC
• Teva Pharmaceutical Industries Ltd.
• Zoetis Inc.
• Novartis AG
• Johnson & Johnson Inc.
• Bristol Myers Squibb Company
• Sandoz International GmbH
• Sun Pharmaceutical Industries Ltd.
• Zydus Lifescience limited
• Lupin Limited
• Aurobindo Pharma Limited
• Fresenius Kabi AG
• Aspen Pharmacare Holdings Limited
• Mylan N.V.
• Sanofi SA
• Wyeth Pharmaceuticals Inc.
• Zhejiang Hisun Pharmaceutical Co. Ltd.
• GlaxoSmithKline plc
What Is The Most Dominant Region In The Aminoglycosides Market?
Asia-Pacific was the largest region in the aminoglycosides market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the aminoglycosides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
